- Home
- DEO vs CAH Comparison
DEO vs CAH Comparison
Compare DEO & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DEO | CAH |
|---|---|---|
| Founded | 1886 | 1979 |
| Country | United Kingdom | United States |
| Employees | 29860 | N/A |
| Industry | Beverages (Production/Distribution) | Other Pharmaceuticals |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.4B | 48.2B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | DEO | CAH |
|---|---|---|
| Price | $79.16 | $198.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $109.00 | ★ $232.27 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 02-25-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.08% | 1.00% |
| EPS Growth | N/A | ★ 86.96 |
| EPS | N/A | ★ 1.88 |
| Revenue | N/A | ★ $222,578,000,000.00 |
| Revenue This Year | $2.65 | $17.36 |
| Revenue Next Year | N/A | $9.06 |
| P/E Ratio | ★ $90.04 | $108.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $72.45 | $136.71 |
| 52 Week High | $116.69 | $233.60 |
Technical Indicators
Market Signals| Indicator | DEO | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 33.76 |
| Support Level | $72.73 | $197.74 |
| Resistance Level | $91.26 | $216.06 |
| Average True Range (ATR) | 1.82 | 4.74 |
| MACD | 0.55 | -1.23 |
| Stochastic Oscillator | 64.45 | 11.01 |
Price Performance
Historical ComparisonAbout DEO Diageo plc
Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.